Zoetis Inc.
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says
Elanco Animal Health (ELAN) seems "best-positioned name" into the Q2 print, with IDEXX Laboratories
Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong Fundamentals
The Best Dividend Stocks screen identifies companies with strong dividends, profitability, and health. Zoetis (ZTS) stands out with a 1.64% yield, 20.56% dividend growth, and low payout ratio.
Why Dividend Investing Often Wins
Dividend growers beat the S&P 500 with lower volatility. Click for a look at my investing strategy and my current top income picks.
Zoetis: Sentiment Keeps Winning As Fundamentals Improve
Zoetis stock trades ~45% below fair value, despite resilient earnings, a low forward P/E, and a 2.8% dividend yield. Learn more. Click for more on ZTS stock.
Temporary Concerns Present Entry Point in Zoetis (ZTS)
Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]
3 Healthcare Stocks with Competitive Advantages
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 10%, nearly mirroring the S&P 500.
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener
Sometimes boring stocks can be the most exciting.
Should You Continue to Hold PAHC Stock in Your Portfolio?
Phibro Animal Health gains from Animal Health strength and Zoetis MFA integration, but macro and FX headwinds remain as the stock rises 27.6% over the past year.
Congressional Trades in $ZTS
Insider Trades (Form 4)
PECK KRISTIN C
Esch Kevin
Driscoll Rimma
FULLER JULIE
Sarbaugh Keith
Ferran Astorga Jeannette
Nayak Abhay U
Lagano Roxanne
Key People
Stetter Mark
Director
SACCARO JAMES
EVP, CFO & COO
Joseph Wetteny
Chief Financial Officer
Driscoll Rimma
Executive Vice President
Nayak Abhay U
Executive Vice President
Esch Kevin
Executive Vice President
Sarbaugh Keith
Executive Vice President
PECK KRISTIN C
Chief Executive Officer
Ferran Astorga Jeannette
Executive Vice President
Lagano Roxanne
Executive Vice President
FULLER JULIE
Executive Vice President
MCCALLISTER MICHAEL B
Director
PARENT LOUISE M
Director
DAMELIO FRANK A
Director
Bisaro Paul
Director
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro